SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-031939
Filing Date
2024-03-07
Accepted
2024-03-07 16:59:59
Documents
1
Period of Report
2024-03-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm248257-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm248257-1_4seq1.xml 4 3377
  Complete submission text file 0001104659-24-031939.txt   4814
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5 OVERLOOK CT LAMBERTVILLE NJ 08530
Business Address
Smith Susan Laura (Reporting) CIK: 0001901039 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38650 | Film No.: 24731052